Europe Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Europe Digital Diabetes Management Market is Segmented Into Monitoring Devices (self-Monitoring Blood Glucose Devices (glucometer Devices, Blood Glucose Test Strips, And Lancets), Continuous Glucose Monitoring Devices (sensors and Durables (receivers and Transmitters))), Management Devices (insulin Pumps (insulin Pump Device, Insulin Pump Reservoir, And Infusion Set), Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, And Jet Injectors), And Geography (France, Germany, Italy, Spain, United Kingdom, Russia, And Rest of Europe). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

Europe Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Europe Diabetes Care Devices Market Size

View Global Report
Europe Diabetes Care Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 8.53 Billion
Market Size (2030) USD 11.51 Billion
CAGR (2025 - 2030) 6.18 %

Major Players

Europe Diabetes Care Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Europe Diabetes Care Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Europe Diabetes Care Devices Market Analysis

The Europe Diabetes Care Devices Market size is estimated at USD 8.53 billion in 2025, and is expected to reach USD 11.51 billion by 2030, at a CAGR of 6.18% during the forecast period (2025-2030).

The European countries are suffering from the burden of high diabetes expenditure due to its rising prevalence. Technological advancements have increased over the period in Diabetes care devices for safer and more accurate administration of insulin. Medtronic launched its first integrated smart insulin pen. The Medtronic Integrated Insulin Pen provides real-time glucose readings of patients along with insulin dose information to manage their glucose levels.

According to IDF, every year, 21,600 children are added to the type-1 diabetic population pool. These figures indicate that approximately 9% of the total healthcare expenditure is spent on diabetes in Europe. Various initiatives by the Government, such as the National Service Framework (NSF) program in the United Kingdom, are improving services by setting national standards to drive up service quality and tackle variations in care. 

The Association of British HealthTech Industries (ABHI) launched a diabetes section, enabling diabetes technology companies to work together in the first forum of its kind. The ABHI group is for any health technology company interested in diabetes care, from CGM and insulin pumps to apps.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Europe Diabetes Care Devices Industry Overview

The Europe Diabetes Care Devices Market is moderately fragmented, with few significant and generic players. Manufacturers drove constant innovations to compete in the market. The major players, such as Abbott and Medtronic, underwent many mergers, acquisitions, and partnerships to establish market dominance while adhering to organic growth strategies. It is evident from the R&D spending of these companies.

Europe Diabetes Care Devices Market Leaders

  1. Roche Diabetes Care

  2. Medtronic PLC

  3. Novo Nordisk A/S

  4. Dexcom Inc.

  5. Abbott

  6. *Disclaimer: Major Players sorted in no particular order
Europe Diabetes Care Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Europe Diabetes Care Devices Market News

  • Feburary 2024: Dexcom launched real-time CGM solution Dexcom ONE+ in Europe. Dexcom ONE+ is a customisable continuous glucose monitoring solution that can be worn at three different location on the body.
  • June 2022: Cequr, the leader in wearable diabetes technology, released its newest and most innovative insulin delivery device, the Insulin Pen 2.0TM. The pen is small enough to be always worn on the user's body, and it also features a built-in blood glucose meter so that users can track their blood sugar throughout the day.

Europe Diabetes Care Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Monitoring Devices
    • 5.1.1 Self-monitoring Blood Glucose Devices
    • 5.1.1.1 Glucometer Devices
    • 5.1.1.2 Blood Glucose Test Strips
    • 5.1.1.3 Lancets
    • 5.1.2 Continuous Glucose Monitoring Devices
    • 5.1.2.1 Sensors
    • 5.1.2.2 Durables (Receivers and Transmitters)
  • 5.2 Management Devices
    • 5.2.1 Insulin Pump
    • 5.2.1.1 Insulin Pump Device
    • 5.2.1.2 Insulin Pump Reservoir
    • 5.2.1.3 Infusion Set
    • 5.2.2 Insulin Syringes
    • 5.2.3 Cartridges in Reusable Pens
    • 5.2.4 Insulin Disposable Pens
    • 5.2.5 Jet Injectors
  • 5.3 Geography
    • 5.3.1 France
    • 5.3.2 Germany
    • 5.3.3 Italy
    • 5.3.4 Spain
    • 5.3.5 United Kingdom
    • 5.3.6 Russia
    • 5.3.7 Rest of Europe

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Dexcom Inc.
    • 7.1.2 Insulet Corporation
    • 7.1.3 Medtronic
    • 7.1.4 Roche Diabetes Care
    • 7.1.5 Novo Nordisk A/S
    • 7.1.6 Ascensia Diabetes Care
    • 7.1.7 Agamatrix Inc.
    • 7.1.8 Bionime Corporation
    • 7.1.9 LifeScan
    • 7.1.10 Abbott Diabetes Care
    • 7.1.11 Eli Lilly
    • 7.1.12 Sanofi
    • 7.1.13 Rossmax
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.3 Insulin Devices

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Diabetes Care Devices Industry Segmentation

Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life. The europe diabetes care devices market is segmented into monitoring devices, management devices and geography. The report offers the value (in usd) and volume (in units) for the above segments.

Monitoring Devices Self-monitoring Blood Glucose Devices Glucometer Devices
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring Devices Sensors
Durables (Receivers and Transmitters)
Management Devices Insulin Pump Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Cartridges in Reusable Pens
Insulin Disposable Pens
Jet Injectors
Geography France
Germany
Italy
Spain
United Kingdom
Russia
Rest of Europe
Need A Different Region or Segment?
Customize Now

Europe Diabetes Care Devices Market Research FAQs

How big is the Europe Diabetes Care Devices Market?

The Europe Diabetes Care Devices Market size is expected to reach USD 8.53 billion in 2025 and grow at a CAGR of 6.18% to reach USD 11.51 billion by 2030.

What is the current Europe Diabetes Care Devices Market size?

In 2025, the Europe Diabetes Care Devices Market size is expected to reach USD 8.53 billion.

Who are the key players in Europe Diabetes Care Devices Market?

Roche Diabetes Care, Medtronic PLC, Novo Nordisk A/S, Dexcom Inc. and Abbott are the major companies operating in the Europe Diabetes Care Devices Market.

What years does this Europe Diabetes Care Devices Market cover, and what was the market size in 2024?

In 2024, the Europe Diabetes Care Devices Market size was estimated at USD 8.00 billion. The report covers the Europe Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Diabetes Care Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Europe Diabetes Care Devices Industry Report

Statistics for the 2025 Europe Diabetes Care Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Diabetes Care Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.